Publication Information

{'id': 'https://openalex.org/W2016425953', 'doi': 'https://doi.org/10.1158/1538-7445.am2014-2965', 'title': 'Abstract 2965: Olaparib and veliparib as effective PARP inhibitors for cancer prevention in a BRCA1-deficient mouse model', 'display_name': 'Abstract 2965: Olaparib and veliparib as effective PARP inhibitors for cancer prevention in a BRCA1-deficient mouse model', 'publication_year': 2014, 'publication_date': '2014-10-01', 'ids': {'openalex': 'https://openalex.org/W2016425953', 'doi': 'https://doi.org/10.1158/1538-7445.am2014-2965', 'mag': '2016425953'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2014-2965', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5020632716', 'display_name': 'Ciric To', 'orcid': 'https://orcid.org/0000-0002-6333-3174'}, 'institutions': [{'id': 'https://openalex.org/I107672454', 'display_name': 'Dartmouth College', 'ror': 'https://ror.org/049s0rh22', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I107672454']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ciric To', 'raw_affiliation_strings': ['Dartmouth College, Hanover, NH.'], 'affiliations': [{'raw_affiliation_string': 'Dartmouth College, Hanover, NH.', 'institution_ids': ['https://openalex.org/I107672454']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036700013', 'display_name': 'Charlotte R. Williams', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I107672454', 'display_name': 'Dartmouth College', 'ror': 'https://ror.org/049s0rh22', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I107672454']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Charlotte R. Williams', 'raw_affiliation_strings': ['Dartmouth College, Hanover, NH.'], 'affiliations': [{'raw_affiliation_string': 'Dartmouth College, Hanover, NH.', 'institution_ids': ['https://openalex.org/I107672454']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047242587', 'display_name': 'Darlene B. Royce', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I107672454', 'display_name': 'Dartmouth College', 'ror': 'https://ror.org/049s0rh22', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I107672454']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Darlene B. Royce', 'raw_affiliation_strings': ['Dartmouth College, Hanover, NH.'], 'affiliations': [{'raw_affiliation_string': 'Dartmouth College, Hanover, NH.', 'institution_ids': ['https://openalex.org/I107672454']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002758038', 'display_name': 'Ryan M. Collins', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I107672454', 'display_name': 'Dartmouth College', 'ror': 'https://ror.org/049s0rh22', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I107672454']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ryan M. Collins', 'raw_affiliation_strings': ['Dartmouth College, Hanover, NH.'], 'affiliations': [{'raw_affiliation_string': 'Dartmouth College, Hanover, NH.', 'institution_ids': ['https://openalex.org/I107672454']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108192090', 'display_name': 'Michael B. Sporn', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I107672454', 'display_name': 'Dartmouth College', 'ror': 'https://ror.org/049s0rh22', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I107672454']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael B. Sporn', 'raw_affiliation_strings': ['Dartmouth College, Hanover, NH.'], 'affiliations': [{'raw_affiliation_string': 'Dartmouth College, Hanover, NH.', 'institution_ids': ['https://openalex.org/I107672454']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5019578505', 'display_name': 'Karen T. Liby', 'orcid': 'https://orcid.org/0000-0003-3317-3437'}, 'institutions': [{'id': 'https://openalex.org/I107672454', 'display_name': 'Dartmouth College', 'ror': 'https://ror.org/049s0rh22', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I107672454']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Karen T. Liby', 'raw_affiliation_strings': ['Dartmouth College, Hanover, NH.'], 'affiliations': [{'raw_affiliation_string': 'Dartmouth College, Hanover, NH.', 'institution_ids': ['https://openalex.org/I107672454']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.158, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.457872, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 73}, 'biblio': {'volume': '74', 'issue': '19_Supplement', 'first_page': '2965', 'last_page': '2965'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/olaparib', 'display_name': 'Olaparib', 'score': 0.9885014}, {'id': 'https://openalex.org/keywords/veliparib', 'display_name': 'Veliparib', 'score': 0.97492707}, {'id': 'https://openalex.org/keywords/parp-inhibitor', 'display_name': 'PARP inhibitor', 'score': 0.84471464}], 'concepts': [{'id': 'https://openalex.org/C2779962180', 'wikidata': 'https://www.wikidata.org/wiki/Q7083106', 'display_name': 'Olaparib', 'level': 5, 'score': 0.9885014}, {'id': 'https://openalex.org/C2781312401', 'wikidata': 'https://www.wikidata.org/wiki/Q7919041', 'display_name': 'Veliparib', 'level': 5, 'score': 0.97492707}, {'id': 'https://openalex.org/C2779138821', 'wikidata': 'https://www.wikidata.org/wiki/Q7118227', 'display_name': 'PARP inhibitor', 'level': 5, 'score': 0.84471464}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6032534}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.58014274}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.56005013}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.5277277}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.5122525}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.50608534}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.44885138}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.32912615}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.321912}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.31348628}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.22501892}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.21403405}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.10624266}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2014-2965', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4389134950', 'https://openalex.org/W4387642987', 'https://openalex.org/W4296617455', 'https://openalex.org/W3134914296', 'https://openalex.org/W2944149590', 'https://openalex.org/W2890903471', 'https://openalex.org/W2604684522', 'https://openalex.org/W2118122348', 'https://openalex.org/W2016425953', 'https://openalex.org/W2003243316'], 'abstract_inverted_index': {'Abstract': [0], 'An': [1], 'inherited': [2], 'mutation': [3, 16, 450], 'in': [4, 92, 98, 123, 133, 150, 152, 221, 232, 245, 345, 351, 360, 366, 374, 376, 428, 448, 481], 'the': [5, 66, 144, 153, 204, 263, 386, 434, 490, 495], 'BRCA1': [6, 49, 63, 449], 'gene': [7], 'leads': [8], 'to': [9, 51, 68, 192, 258, 336, 385, 418, 444], 'genomic': [10], 'instability': [11], 'and': [12, 32, 60, 114, 171, 178, 186, 216, 241, 250, 268, 354, 425, 472], 'those': [13], 'with': [14, 161, 224, 248, 306, 382], 'this': [15, 38, 141], 'have': [17], 'a': [18, 45, 80, 106, 210, 297, 482], '50-80%': [19], 'risk': [20, 447], 'for': [21, 37, 126, 208, 292, 436, 478, 498], 'developing': [22], 'breast': [23, 127], 'cancer': [24, 128, 134, 446, 479], 'by': [25, 184, 239, 296, 312, 396, 422], 'age': [26], '70.': [27], 'Though': [28], 'bilateral': [29], 'prophylactic': [30], 'mastectomy': [31], 'surveillance': [33], 'are': [34, 116, 121], 'viable': [35], 'options': [36], 'high-risk': [39], 'population,': [40], 'chemoprevention': [41, 151], 'may': [42, 95], 'serve': [43], 'as': [44, 61, 76, 319, 321, 440, 474], 'good': [46], 'alternative': [47], 'strategy.': [48], 'functions': [50], 'repair': [52, 73], 'double': [53], 'stranded': [54], 'DNA': [55, 72], 'breaks': [56], 'via': [57], 'homologous': [58], 'recombination': [59], 'such,': [62], 'mutations': [64], 'force': [65], 'cells': [67, 94, 111], 'rely': [69], 'on': [70], 'other': [71], 'mechanisms': [74], 'such': [75], 'base': [77], 'excision': [78], 'repair,': [79], 'process': [81], 'which': [82, 101, 316], 'requires': [83], 'Poly': [84], 'ADP': [85], 'ribose': [86], 'polymerase': [87], '(PARP).': [88], 'Thus,': [89], 'PARP': [90, 118, 148, 438, 476], 'inhibition': [91], 'BRCA1-deficient': [93, 429, 483], 'induce': [96], 'apoptosis': [97, 375, 427], 'these': [99, 147, 404], 'cells,': [100], 'would': [102], 'otherwise': [103], 'develop': [104], 'into': [105], 'tumor,': [107], 'while': [108], 'leaving': [109], 'normal': [110], 'intact.': [112], 'Olaparib': [113, 471], 'veliparib': [115, 167, 179, 473], 'promising': [117], 'inhibitors': [119, 149, 439, 477], 'that': [120, 328, 407, 413], 'currently': [122], 'clinical': [124], 'trials': [125], 'treatment;': [129], 'however,': [130], 'their': [131, 193, 259, 337], 'role': [132], 'prevention': [135, 480], 'has': [136], 'not': [137], 'been': [138], 'examined.': [139], 'Hence,': [140], 'study': [142, 213], 'evaluated': [143], 'effect': [145], 'of': [146, 230, 253, 265, 275, 289, 301, 369, 489, 494], 'BrcaCo/Co;MMTV-Cre;p53+/-': [154], 'mouse': [155, 484], 'model.': [156, 485], 'Mice': [157], 'were': [158], 'fed': [159, 223, 247], 'continuously': [160], 'olaparib': [162, 177, 196, 231, 254, 290, 307, 323, 329, 383, 408], '(200': [163], 'mg/kg': [164, 169, 229, 252, 288], 'diet)': [165, 170], 'or': [166, 227], '(100': [168], 'tumor': [172, 182, 217, 310, 420], 'development': [173, 183, 218, 235, 311, 421], 'was': [174, 197, 214, 219, 236, 281, 317, 393], 'assessed.': [175], 'Both': [176], 'significantly': [180, 237, 308, 330], 'delayed': [181, 238, 309], '6.5': [185], '2.4': [187], 'weeks': [188, 243, 294, 314, 356], 'respectively': [189, 256], '(p<0.05)': [190, 244, 333], 'compared': [191, 257, 335, 384], 'controls': [194, 338], 'but': [195], 'more': [198], 'effective': [199, 320, 411, 475], 'than': [200], 'veliparib.': [201], 'To': [202, 261], 'determine': [203], 'lowest': [205], 'dose': [206, 211], 'required': [207], 'prevention,': [209], 'de-escalation': [212], 'done': [215], 'assessed': [220], 'mice': [222, 246, 284, 380], '100,': [225], '50,': [226], '25': [228], 'diet.': [233, 303], 'Tumor': [234], '3.2': [240], '3.5': [242], '50': [249], '100': [251], 'diets': [255], 'controls.': [260], 'circumvent': [262], 'possibility': [264], 'drug': [266, 270], 'resistance': [267], 'adverse': [269], 'reaction': [271], 'from': [272, 379], 'prolonged': [273], 'use': [274], 'olaparib,': [276], 'an': [277, 410], 'intermittent': [278], 'dosing': [279], 'regimen': [280], 'examined': [282], 'where': [283], 'cycled': [285], 'through': [286], '200': [287], 'diet': [291], '2': [293], 'followed': [295], '4-week': [298], 'rest': [299], 'period': [300], 'control': [302, 387], 'Intermittent': [304], 'treatment': [305], '5.7': [313], '(p<0.05),': [315], 'almost': [318], 'continuous': [322], 'treatment.': [324], 'BrdU': [325], 'staining': [326, 398], 'revealed': [327], 'reduced': [331], 'proliferation': [332, 424], 'when': [334], 'at': [339, 399], 'both': [340], '24': [341], '(9.9%': [342], 'vs.': [343, 349, 358, 364, 390], '13.5%': [344], 'hyperplastic': [346, 361, 377], 'areas;': [347, 362], '4.5%': [348], '9.5%': [350], 'mammary': [352, 367], 'ducts)': [353, 368], '30': [355, 400], '(9%': [357], '15.9%': [359], '8.9%': [363], '17.6%': [365], 'age.': [370], 'A': [371], 'significant': [372], 'increase': [373], 'areas': [378], 'treated': [381], 'group': [388], '(12.3%': [389], '8.4%;': [391], 'p<0.05)': [392], 'also': [394], 'observed': [395], 'TUNEL': [397], 'weeks.': [401], 'Taken': [402], 'together,': [403], 'studies': [405], 'demonstrated': [406], 'is': [409], 'agent': [412], 'can': [414], 'be': [415], 'used': [416], 'intermittently': [417], 'delay': [419], 'reducing': [423], 'inducing': [426], 'mice.': [430], 'These': [431], 'results': [432], 'highlight': [433], 'potential': [435], 'using': [437], 'novel': [441], 'preventive': [442], 'strategies': [443], 'manage': [445], 'carriers.': [451], 'Citation': [452], 'Format:': [453], 'Ciric': [454], 'To,': [455], 'Charlotte': [456], 'R.': [457], 'Williams,': [458], 'Darlene': [459], 'B.': [460, 466], 'Royce,': [461], 'Ryan': [462], 'M.': [463], 'Collins,': [464], 'Michael': [465], 'Sporn,': [467], 'Karen': [468], 'T.': [469], 'Liby.': [470], '[abstract].': [486], 'In:': [487], 'Proceedings': [488], '105th': [491], 'Annual': [492], 'Meeting': [493], 'American': [496], 'Association': [497], 'Cancer': [499, 510], 'Research;': [500], '2014': [501], 'Apr': [502], '5-9;': [503], 'San': [504], 'Diego,': [505], 'CA.': [506], 'Philadelphia': [507], '(PA):': [508], 'AACR;': [509], 'Res': [511], '2014;74(19': [512], 'Suppl):Abstract': [513], 'nr': [514], '2965.': [515], 'doi:10.1158/1538-7445.AM2014-2965': [516]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2016425953', 'counts_by_year': [{'year': 2017, 'cited_by_count': 1}], 'updated_date': '2024-12-08T12:48:31.831039', 'created_date': '2016-06-24'}